TQCCX
Price
$19.52
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VIVAX
Price
$69.44
Change
+$0.09 (+0.13%)
Updated
Nov 13 closing price
Ad is loading...

TQCCX vs VIVAX

Header iconTQCCX vs VIVAX Comparison
Open Charts TQCCX vs VIVAXBanner chart's image
Touchstone Dividend Equity C
Price$19.52
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.44
Change+$0.09 (+0.13%)
VolumeN/A
CapitalizationN/A
TQCCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TQCCX vs. VIVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TQCCX is a Buy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. TQCCX (2.51B). VIVAX pays higher dividends than TQCCX: VIVAX (2.25) vs TQCCX (1.38). TQCCX was incepted earlier than VIVAX: TQCCX (26 years) vs VIVAX (32 years). TQCCX is a more actively managed with annual turnover of: 13.00 vs. VIVAX (10.00). TQCCX has a lower initial minimum investment than VIVAX: TQCCX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 27.17 vs. TQCCX (24.89). VIVAX return over 5 years is better than : 52.39 vs. TQCCX (20.54).
TQCCXVIVAXTQCCX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years32 years-
Gain YTD15.86819.14883%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.51B184B1%
Annual Yield % from dividends1.382.2562%
Returns for 1 year24.8927.1792%
Returns for 3 years12.0022.6853%
Returns for 5 years20.5452.3939%
Returns for 10 years28.04114.1025%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRNT2.780.22
+8.63%
Ceragon Networks Ltd
NXPL1.170.02
+1.73%
NextPlat Corp
FICO2348.450.35
+0.01%
Fair Isaac Corp
DNLI29.64-0.25
-0.84%
Denali Therapeutics
TRUP52.57-1.18
-2.20%
Trupanion